Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma

*Department of Pathology

†Peter O’Donnell School of Public Health

§Department of Urology, University of Texas Southwestern Medical Center

‡Kidney Cancer Program at Simmons Comprehensive Cancer Center, Dallas, TX

P.K. is supported by grants from NIH (P50CA196516, R01CA244579, R01CA15447, and R01DK115986), DOD (W81XWH-16-1-0474, W81XWH1910710 and KC200285), and CPRIT (RP200233 and RP220294). L.G.C. is supported by grants from NIH (1R01NS123398, P50CA196516, R01NS102417, ULTR003163, U24AI177622), DOD (KC200285), PCORI (C00078315, RD-2020C2-20329), and CDC (5 NU38OT000316-05-00).

The authors have no funding or conflicts of interest to disclose.

Reprints: Payal Kapur, MD, Kidney Cancer Program, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard. (e-mail: [email protected]).

All figures can be viewed online in color at www.anatomicpathology.com.

留言 (0)

沒有登入
gif